메뉴 건너뛰기




Volumn 118, Issue 4-5, 2010, Pages 277-282

Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines

Author keywords

Aromatase inhibitor; Estrogen receptor; Microarray; Resistance

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AMPHIREGULIN; ANASTROZOLE; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; EXEMESTANE; LETROZOLE; MICRORNA; TAMOXIFEN; TESTOSTERONE; UO 126; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE; NITRILE; TRIAZOLE DERIVATIVE;

EID: 77950357673     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.10.011     Document Type: Conference Paper
Times cited : (40)

References (32)
  • 1
    • 15544365329 scopus 로고    scopus 로고
    • Selective estrogen-receptor modulators for primary prevention of breast cancer
    • C.J. Fabian, B.F. Kimler, Selective estrogen-receptor modulators for primary prevention of breast cancer, J. Clin. Oncol. 23 (8) (2005) 1644-1655.
    • (2005) J. Clin. Oncol. , vol.23 , Issue.8 , pp. 1644-1655
    • Fabian, C.J.1    Kimler, B.F.2
  • 2
    • 18844443185 scopus 로고    scopus 로고
    • Aromatase inhibitors in the treatment of breast cancer
    • R.W. Brueggemeier, J.C. Hackett, E.S. Diaz-Cruz, Aromatase inhibitors in the treatment of breast cancer, Endocr. Rev. 26 (3) (2005) 331-345.
    • (2005) Endocr. Rev. , vol.26 , Issue.3 , pp. 331-345
    • Brueggemeier, R.W.1    Hackett, J.C.2    Diaz-Cruz, E.S.3
  • 3
    • 33846619697 scopus 로고    scopus 로고
    • Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase
    • Y. Hong, B. Yu, M. Sherman, Y.C. Yuan, D. Zhou, S. Chen, Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase, Mol. Endocrinol. 21 (2) (2007) 401-414.
    • (2007) Mol. Endocrinol. , vol.21 , Issue.2 , pp. 401-414
    • Hong, Y.1    Yu, B.2    Sherman, M.3    Yuan, Y.C.4    Zhou, D.5    Chen, S.6
  • 4
    • 33947510501 scopus 로고    scopus 로고
    • Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: Update of study BIG 1-98
    • A.S. Coates, A. Keshaviah, B. Thurlimann, H. Mouridsen, L. Mauriac, J.F. Forbes, R. Paridaens, M. Castiglione-Gertsch, R.D. Gelber, M. Colleoni, et al., Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98, J. Clin. Oncol. 25 (5) (2007) 486-492.
    • (2007) J. Clin. Oncol. , vol.25 , Issue.5 , pp. 486-492
    • Coates, A.S.1    Keshaviah, A.2    Thurlimann, B.3    Mouridsen, H.4    Mauriac, L.5    Forbes, J.F.6    Paridaens, R.7    Castiglione-Gertsch, M.8    Gelber, R.D.9    Colleoni, M.10
  • 7
    • 11444251764 scopus 로고    scopus 로고
    • Results of the ATAC (Arimidex, Tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    • A. Howell, J. Cuzick, M. Baum, A. Buzdar, M. Dowsett, J.F. Forbes, G. Hoctin-Boes, J. Houghton, G.Y. Locker, J.S. Tobias, Results of the ATAC (Arimidex, Tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer, Lancet 365 (9453) (2005) 60-62.
    • (2005) Lancet , vol.365 , Issue.9453 , pp. 60-62
    • Howell, A.1    Cuzick, J.2    Baum, M.3    Buzdar, A.4    Dowsett, M.5    Forbes, J.F.6    Hoctin-Boes, G.7    Houghton, J.8    Locker, G.Y.9    Tobias, J.S.10
  • 8
    • 49649111492 scopus 로고    scopus 로고
    • Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor
    • S. Masri, S. Phung, X. Wang, X. Wu, Y.C. Yuan, L. Wagman, S. Chen, Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor, Cancer Res. 68 (12) (2008) 4910-4918.
    • (2008) Cancer Res. , vol.68 , Issue.12 , pp. 4910-4918
    • Masri, S.1    Phung, S.2    Wang, X.3    Wu, X.4    Yuan, Y.C.5    Wagman, L.6    Chen, S.7
  • 9
    • 70349578803 scopus 로고    scopus 로고
    • Characterization of the weak estrogen receptor alpha agonistic activity of exemestane
    • S. Masri, K. Lui, S. Phung, J. Ye, D. Zhou, X. Wang, S. Chen, Characterization of the weak estrogen receptor alpha agonistic activity of exemestane, Breast Cancer Res. Treat. 116 (3) (2009) 461-470.
    • (2009) Breast Cancer Res. Treat. , vol.116 , Issue.3 , pp. 461-470
    • Masri, S.1    Lui, K.2    Phung, S.3    Ye, J.4    Zhou, D.5    Wang, X.6    Chen, S.7
  • 10
    • 42049120692 scopus 로고    scopus 로고
    • The role of amphiregulin in exemestaneresistant breast cancer cells: Evidence of an autocrine loop
    • X. Wang, S. Masri, S. Phung, S. Chen, The role of amphiregulin in exemestaneresistant breast cancer cells: evidence of an autocrine loop, Cancer Res. 68 (7) (2008) 2259-2265.
    • (2008) Cancer Res. , vol.68 , Issue.7 , pp. 2259-2265
    • Wang, X.1    Masri, S.2    Phung, S.3    Chen, S.4
  • 11
    • 0031458548 scopus 로고    scopus 로고
    • Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells
    • X.Z. Sun, D. Zhou, S. Chen, Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells, J. Steroid Biochem. Mol. Biol. 63 (1-3) (1997) 29-36.
    • (1997) J. Steroid Biochem. Mol. Biol. , vol.63 , Issue.1-3 , pp. 29-36
    • Sun, X.Z.1    Zhou, D.2    Chen, S.3
  • 13
    • 33751275796 scopus 로고    scopus 로고
    • Aromatase destabilizer: Novel action of exemestane, a food and drug administration-approved aromatase inhibitor
    • X. Wang, S. Chen, Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor, Cancer Res. 66 (21) (2006) 10281-10286.
    • (2006) Cancer Res. , vol.66 , Issue.21 , pp. 10281-10286
    • Wang, X.1    Chen, S.2
  • 14
    • 34247266976 scopus 로고    scopus 로고
    • Aromatase inhibitors and bone health in women with breast cancer
    • A.J. Chien, P.E. Goss, Aromatase inhibitors and bone health in women with breast cancer, J. Clin. Oncol. 24 (33) (2006) 5305-5312.
    • (2006) J. Clin. Oncol. , vol.24 , Issue.33 , pp. 5305-5312
    • Chien, A.J.1    Goss, P.E.2
  • 15
    • 33748776260 scopus 로고    scopus 로고
    • Bone safety of aromatase inhibitors versus tamoxifen
    • P.E. Lonning, Bone safety of aromatase inhibitors versus tamoxifen, Int. J. Gynecol. Cancer 16 (Suppl. 2) (2006) 518-520.
    • (2006) Int. J. Gynecol. Cancer , vol.16 , Issue.SUPPL. 2 , pp. 518-520
    • Lonning, P.E.1
  • 16
    • 38549180762 scopus 로고    scopus 로고
    • Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer
    • E.A. Perez, Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer, Ann. Oncol. 18 (Suppl. 8) (2007), viii26-35.
    • (2007) Ann. Oncol. , vol.18 , Issue.SUPPL. 8
    • Perez, E.A.1
  • 17
    • 33846545488 scopus 로고    scopus 로고
    • Skeletal effects of exemestane on bonemineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): A randomised controlled study
    • R.E. Coleman, L.M. Banks, S.I. Girgis, L.S. Kilburn, E. Vrdoljak, J. Fox, S.J. Cawthorn, A. Patel, C.F. Snowdon, E. Hall, et al., Skeletal effects of exemestane on bonemineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study, Lancet Oncol. 8 (2) (2007) 119-127.
    • (2007) Lancet Oncol. , vol.8 , Issue.2 , pp. 119-127
    • Coleman, R.E.1    Banks, L.M.2    Girgis, S.I.3    Kilburn, L.S.4    Vrdoljak, E.5    Fox, J.6    Cawthorn, S.J.7    Patel, A.8    Snowdon, C.F.9    Hall, E.10
  • 18
    • 36549088561 scopus 로고    scopus 로고
    • Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
    • P.E. Goss, P. Hadji, M. Subar, P. Abreu, T. Thomsen, J. Banke-Bochita, Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women, Breast Cancer Res. 9 (4) (2007) R52.
    • (2007) Breast Cancer Res. , vol.9 , Issue.4
    • Goss, P.E.1    Hadji, P.2    Subar, M.3    Abreu, P.4    Thomsen, T.5    Banke-Bochita, J.6
  • 19
    • 1242338758 scopus 로고    scopus 로고
    • Selective estrogen receptor modulators: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells
    • J. Frasor, F. Stossi, J.M. Danes, B. Komm, C.R. Lyttle, B.S. Katzenellenbogen, Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells, Cancer Res. 64 (4) (2004) 1522-1533.
    • (2004) Cancer Res. , vol.64 , Issue.4 , pp. 1522-1533
    • Frasor, J.1    Stossi, F.2    Danes, J.M.3    Komm, B.4    Lyttle, C.R.5    Katzenellenbogen, B.S.6
  • 20
    • 0029092283 scopus 로고
    • Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines
    • I. Martinez-Lacaci, M. Saceda, G.D. Plowman, G.R. Johnson, N. Normanno, D.S. Salomon, R.B. Dickson, Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines, Endocrinology 136 (9) (1995) 3983-3992.
    • (1995) Endocrinology , vol.136 , Issue.9 , pp. 3983-3992
    • Martinez-Lacaci, I.1    Saceda, M.2    Plowman, G.D.3    Johnson, G.R.4    Normanno, N.5    Salomon, D.S.6    Dickson, R.B.7
  • 22
    • 0024593476 scopus 로고
    • Structure and function ofhumanamphiregulin: Amember of the epidermal growth factor family
    • M. Shoyab, G.D. Plowman, V.L. McDonald, J.G. Bradley, G.J. Todaro, Structure and function ofhumanamphiregulin: amember of the epidermal growth factor family, Science 243 (4894 Pt 1) (1989) 1074-1076.
    • (1989) Science , vol.243 , Issue.4894 PART 1 , pp. 1074-1076
    • Shoyab, M.1    Plowman, G.D.2    McDonald, V.L.3    Bradley, J.G.4    Todaro, G.J.5
  • 23
  • 24
    • 0027416692 scopus 로고
    • Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen
    • K. Akakura, N. Bruchovsky, S.L. Goldenberg, P.S. Rennie, A.R. Buckley, L.D. Sullivan, Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen, Cancer 71 (9) (1993) 2782-2790.
    • (1993) Cancer , vol.71 , Issue.9 , pp. 2782-2790
    • Akakura, K.1    Bruchovsky, N.2    Goldenberg, S.L.3    Rennie, P.S.4    Buckley, A.R.5    Sullivan, L.D.6
  • 25
    • 0027287757 scopus 로고
    • Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline
    • J.T. Hsieh, H.C. Wu, M.E. Gleave, A.C. von Eschenbach, L.W. Chung, Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline, Cancer Res. 53 (12) (1993) 2852-2857.
    • (1993) Cancer Res. , vol.53 , Issue.12 , pp. 2852-2857
    • Hsieh, J.T.1    Wu, H.C.2    Gleave, M.E.3    Von Eschenbach, A.C.4    Chung, L.W.5
  • 26
    • 57649174634 scopus 로고    scopus 로고
    • MicroRNA-221/222 negatively regulates estrogen receptor{alpha} and is associated with tamoxifen resistance in breast cancer
    • J.J. Zhao, J. Lin, H. Yang, W. Kong, L. He, X. Ma, D. Coppola, J.Q. Cheng, MicroRNA-221/222 negatively regulates estrogen receptor{alpha} and is associated with tamoxifen resistance in breast cancer, J. Biol. Chem. 283 (45) (2008) 31079-31086.
    • (2008) J. Biol. Chem. , vol.283 , Issue.45 , pp. 31079-31086
    • Zhao, J.J.1    Lin, J.2    Yang, H.3    Kong, W.4    He, L.5    Ma, X.6    Coppola, D.7    Cheng, J.Q.8
  • 30
    • 44949249814 scopus 로고    scopus 로고
    • MiR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
    • L. Xia, D. Zhang, R. Du, Y. Pan, L. Zhao, S. Sun, L. Hong, J. Liu, D. Fan, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells, Int. J. Cancer 123 (2) (2008) 372-379.
    • (2008) Int. J. Cancer , vol.123 , Issue.2 , pp. 372-379
    • Xia, L.1    Zhang, D.2    Du, R.3    Pan, Y.4    Zhao, L.5    Sun, S.6    Hong, L.7    Liu, J.8    Fan, D.9
  • 32
    • 39049086391 scopus 로고    scopus 로고
    • MicroRNA expression profiling in human ovarian cancer: MiR-214 induces cell survival and cisplatin resistance by targeting PTEN
    • H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, J. Wang, R.M. Wenham, D. Coppola, P.A. Kruk, S.V. Nicosia, et al., MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN, Cancer Res. 68 (2) (2008) 425-433.
    • (2008) Cancer Res. , vol.68 , Issue.2 , pp. 425-433
    • Yang, H.1    Kong, W.2    He, L.3    Zhao, J.J.4    O'Donnell, J.D.5    Wang, J.6    Wenham, R.M.7    Coppola, D.8    Kruk, P.A.9    Nicosia, S.V.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.